Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis-Reference-Cited by-全球学者库

Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis

Published:2014-09-15 Issue:9 Volume:9 Page:e107161
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Yaxiong,Sheng Jin,Kang Shiyang,Fang Wenfeng,Yan Yue,Hu Zhihuang,Hong Shaodong,Wu Xuan,Qin Tao,Liang Wenhua,Zhang Li

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Cancer statistics, 2010;A Jemal;CA Cancer J Clin,2010

2. Optimizing first-line treatment options for patients with advanced NSCLC;H Wakelee;Oncologist,2005

3. Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions;S Ramalingam;Oncologist,2008

4. Lung cancer;RS Herbst;N Engl J Med,2008

5. Treatment of non-small-cell lung cancer with erlotinib or gefitinib;VD Cataldo;N Engl J Med,2011

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of thyroid transcription factor 1 and napsin A to predict local failure and survival after Gamma Knife radiosurgery in patients with brain metastases from lung adenocarcinoma;Journal of Neurosurgery;2023-03-01

2. Genomic features and its potential implication in bone oligometastatic NSCLC;BMC Pulmonary Medicine;2023-02-08

3. Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma;Diagnostics;2023-01-20

4. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer;Journal of Personalized Medicine;2023-01-17

5. Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: a prospective observational study;BMC Cancer;2022-12-17